Lindsay Lundberg

935 citations

21 papers · 735 indexed · h-index 17

Infectious Diseases top 5%
Public Health, Environmental and Occupational Health top 5%
Molecular Biology
Epidemiology
Virology top 10%

Co-authors: Kylene Kehn‐Hall Chelsea Pinkham Aarthi Narayanan Alan N. Baer David A. Jans Kylie M. Wagstaff Brian D. Carey Moushimi Amaya
Topics: Mosquito-borne diseases and control (12 papers)Viral Infections and Vectors (10 papers)Viral Infections and Outbreaks Research (9 papers)
Cited by: Infectious Diseases Virology Public Health, Environmental and Occupational Health
Journals: Journal of Biological Chemistry PLoS ONE Journal of Virology
Partner nations: United States Australia Sweden

In The Last Decade

Lindsay Lundberg

21 papers receiving 725 citations

Peers

Countries citing papers authored by Lindsay Lundberg

Since Specialization

Citations

This map shows the geographic impact of Lindsay Lundberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay Lundberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay Lundberg more than expected).

Fields of papers citing papers by Lindsay Lundberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay Lundberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay Lundberg. The network helps show where Lindsay Lundberg may publish in the future.

Co-authorship network of co-authors of Lindsay Lundberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay Lundberg. A scholar is included among the top collaborators of Lindsay Lundberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay Lundberg. Lindsay Lundberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity 2019 ·Scientific Reports ·Aaron DeBono,David R. Thomas,Lindsay Lundberg,Chelsea Pinkham,Ying Cao,J. Dinny Graham,Christine L. Clarke,Kylie M. Wagstaff,Sharon Shechter,Kylene Kehn‐Hall,David A. Jans	13
2	Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening 2018 ·Antiviral Research ·David R. Thomas,Lindsay Lundberg,Chelsea Pinkham,Sharon Shechter,Aaron DeBono,Jonathan B. Baell,Kylie M. Wagstaff,Caroline A. Hick,Kylene Kehn‐Hall,David A. Jans	27
3	Venezuelan Equine Encephalitis Virus Capsid Implicated in Infection-Induced Cell Cycle Delay in vitro 2018 ·Frontiers in Microbiology ·Lindsay Lundberg,(unknown),Shih‐Chao Lin,Chelsea Pinkham,Brian D. Carey,Catherine E. Campbell,Kylene Kehn‐Hall	17
4	Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses 2018 ·Antiviral Research ·Lindsay Lundberg,(unknown),Idris Hooper,Brian D. Carey,Shih‐Chao Lin,(unknown),Aarthi Narayanan,Kylene Kehn‐Hall	37
5	Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication 2018 ·Viruses ·Todd M. Bell,Virginia Espina,Lindsay Lundberg,Chelsea Pinkham,(unknown),Brian D. Carey,Shih‐Chao Lin,(unknown),(unknown),Cynthia de la Fuente,Lance A. Liotta,Charles Bailey,Kylene Kehn‐Hall	4
6	Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis 2017 ·Antiviral Research ·Todd M. Bell,Virginia Espina,Svetlana Senina,(unknown),(unknown),Brian D. Carey,Shih‐Chao Lin,Lindsay Lundberg,Chelsea Pinkham,Alan N. Baer,Claudius Mueller,Elizabeth A. Chlipala,(unknown),Cynthia de la Fuente,Lance A. Liotta,Kylene Kehn‐Hall	19
7	Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug-Design 2017 ·Scientific Reports ·Sharon Shechter,David R. Thomas,Lindsay Lundberg,Chelsea Pinkham,Shih‐Chao Lin,Kylie M. Wagstaff,Aaron DeBono,Kylene Kehn‐Hall,David A. Jans	26
8	Venezuelan Equine Encephalitis Virus Capsid—The Clever Caper 2017 ·Viruses ·Lindsay Lundberg,Brian D. Carey,Kylene Kehn‐Hall	36
9	The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection 2016 ·Virology ·Chelsea Pinkham,Soyeon An,Lindsay Lundberg,Neha Bansal,(unknown),Aarthi Narayanan,Kylene Kehn‐Hall	11
10	Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells 2016 ·PLoS neglected tropical diseases ·Lindsay Lundberg,Chelsea Pinkham,Cynthia de la Fuente,(unknown),Nazly Shafagati,Kylie M. Wagstaff,David A. Jans,Sharon Tamir,Kylene Kehn‐Hall	36
11	Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1 2016 ·Journal of Virology ·Alan N. Baer,Lindsay Lundberg,(unknown),(unknown),Chelsea Pinkham,Jonathan D. Dinman,Jonathan L. Jacobs,Kylene Kehn‐Hall	48
12	Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection 2015 ·Frontiers in Microbiology ·(unknown),Neha Bansal,Svetlana Senina,Idris Hooper,Lindsay Lundberg,Cynthia de la Fuente,Aarthi Narayanan,(unknown),Kylene Kehn‐Hall	39
13	The Use of Nanotrap Particles in the Enhanced Detection of Rift Valley Fever Virus Nucleoprotein 2015 ·PLoS ONE ·Nazly Shafagati,Lindsay Lundberg,Alan N. Baer,Alexis Patanarut,(unknown),Benjamin Lepene,Kylene Kehn‐Hall	14
14	The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics 2014 ·Pathogens and Disease ·Nazly Shafagati,Alexis Patanarut,Alessandra Luchini,Lindsay Lundberg,Charles Bailey,Emanuel F. Petricoin,Lance A. Liotta,Aarthi Narayanan,Benjamin Lepene,Kylene Kehn‐Hall	24
15	Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication 2013 ·Antiviral Research ·Lindsay Lundberg,Chelsea Pinkham,Alan N. Baer,Moushimi Amaya,Aarthi Narayanan,Kylie M. Wagstaff,David A. Jans,Kylene Kehn‐Hall	142
16	Design of potential bisubstrate inhibitors against Mycobacterium tuberculosis (Mtb) 1-deoxy-d-xylulose 5-phosphate reductoisomerase (Dxr)—evidence of a novel binding mode 2013 ·MedChemComm ·(unknown),(unknown),(unknown),(unknown),Amanda Haymond,Lindsay Lundberg,Chelsea Pinkham,Kylene Kehn‐Hall,Helena I. Boshoff,Robin D. Couch,Cynthia S. Dowd	23
17	p53 Activation following Rift Valley Fever Virus Infection Contributes to Cell Death and Viral Production 2012 ·PLoS ONE ·(unknown),Alan N. Baer,Lindsay Lundberg,Nazly Shafagati,(unknown),Aarthi Narayanan,(unknown),Jean‐Jacques Panthier,Fatah Kashanchi,Charles Bailey,Kylene Kehn‐Hall	45
18	Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells 2012 ·Journal of Biological Chemistry ·Aarthi Narayanan,Kylene Kehn‐Hall,Svetlana Senina,Lindsay Lundberg,Rachel Van Duyne,Irene Guendel,Ravi Das,Alan N. Baer,(unknown),Michael J. Turell,Amy L. Hartman,Bhaskar C. Das,Charles Bailey,Fatah Kashanchi	61
19	Modulation of GSK-3β Activity in Venezuelan Equine Encephalitis Virus Infection 2012 ·PLoS ONE ·Kylene Kehn‐Hall,Aarthi Narayanan,Lindsay Lundberg,Gavin C. Sampey,Chelsea Pinkham,Irene Guendel,Rachel Van Duyne,Svetlana Senina,Kimberly L. W. Schultz,Eric Stavale,M. Javad Aman,Charles Bailey,Fatah Kashanchi	44
20	Heroin impurity profiling 2000 ·Forensic Science International ·Lars Strömberg,Lindsay Lundberg,Helmut Neumann,(unknown),H. Huizer,(unknown)	42

About Lindsay Lundberg

Lindsay Lundberg is a scholar working on Virology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 735 indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (12 papers), Viral Infections and Vectors (10 papers) and Viral Infections and Outbreaks Research (9 papers). The work is most often cited by research in Infectious Diseases (392 citations), Virology (63 citations) and Public Health, Environmental and Occupational Health (294 citations). Lindsay Lundberg has collaborated with scholars based in United States, Australia and Sweden. Frequent co-authors include Kylene Kehn‐Hall, Chelsea Pinkham, Aarthi Narayanan, Alan N. Baer, David A. Jans, Kylie M. Wagstaff, Brian D. Carey, Moushimi Amaya, Svetlana Senina and Charles Bailey. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact